Gulati Martha, Mulvagh Sharon L
Division of Cardiology, University of Arizona-Phoenix, Phoenix, Arizona.
Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Clin Cardiol. 2018 Feb;41(2):253-257. doi: 10.1002/clc.22886. Epub 2018 Feb 15.
Cardiovascular disease remains the leading cause of death in women in the United States and is a major public health issue for all women, but it is of increasing concern to breast cancer survivors. Advancements in early detection and breast cancer therapy have resulted in over 90% of women surviving 5 years past their diagnosis of breast cancer. Nonetheless, with increased survivorship from breast cancer, there has been an increase in cardiovascular disease in these women. The consequences of the treatments for breast cancer may increase the risk for cardiovascular disease. Additionally, there is an overlap of risk factors common to both breast cancer and cardiovascular disease. The increased risk of cardiovascular disease in women who survive breast cancer must be recognized, with a focus on the prevention and early detection of cardiovascular disease.
在美国,心血管疾病仍是女性的首要死因,是所有女性面临的一个重大公共卫生问题,不过它越来越受到乳腺癌幸存者的关注。早期检测和乳腺癌治疗方面的进展已使超过90%的女性在被诊断出乳腺癌后存活5年以上。尽管如此,随着乳腺癌幸存者人数的增加,这些女性患心血管疾病的人数也有所上升。乳腺癌治疗的后果可能会增加患心血管疾病的风险。此外,乳腺癌和心血管疾病有一些共同的风险因素。必须认识到乳腺癌幸存者患心血管疾病的风险增加,重点是预防和早期检测心血管疾病。